Saladax Biomedical, Inc.-Product Pipeline Analysis, 2016 Update

Saladax Biomedical, Inc.-Product Pipeline Analysis, 2016 Update

  • Products Id :- GDME2294PD
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Saladax Biomedical, Inc. (Saladax) is a diagnostic company that develops diagnostic tests for the delivery of medicine in oncology. The company's products include My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel. Its My5-FU measures and helps physicians to optimize a patient's exposure to 5-fluorouracil; MyPaclitaxel is blood test used to measure exposure of patient to paclitaxel; and MyDocetaxel measures patient's exposure to docetaxel. Saladax's MyImatinib measures and helps physicians optimize a patient's exposure to imatinib. The company's products are used in the treatment of cell lung cancer, digestive tract, prostate, and head and neck cancers. It markets products through a network of distributors in different parts of the world. Saladax is headquartered in Bethlehem, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Saladax Biomedical, Inc.

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Saladax Biomedical, Inc. Company Snapshot 6

Saladax Biomedical, Inc. Company Overview 6

Saladax Biomedical, Inc. Pipeline Products and Clinical Trials Overview 7

Saladax Biomedical, Inc.-Pipeline Analysis Overview 9

Key Facts 9

Saladax Biomedical, Inc.-Major Products and Services 10

Saladax Biomedical, Inc. Pipeline Products by Development Stage 11

Saladax Biomedical, Inc. Pipeline Products Overview 13

Diagnostic Assay-Alzheimer's Disease 13

Diagnostic Assay-Alzheimer's Disease Product Overview 13

MyCare Assay-Busulfan 14

MyCare Assay-Busulfan Product Overview 14

MyCare Assay-Clozapine 15

MyCare Assay-Clozapine Product Overview 15

MyCare Assay-Cyclophosphamide 16

MyCare Assay-Cyclophosphamide Product Overview 16

MyCare Assay-Doxorubicin 17

MyCare Assay-Doxorubicin Product Overview 17

MyCare Assay-Gemcitabine 18

MyCare Assay-Gemcitabine Product Overview 18

MyCare Assay-Irinotecan 19

MyCare Assay-Irinotecan Product Overview 19

MyCare Assay-Lenalidomide 20

MyCare Assay-Lenalidomide Product Overview 20

MyCare Assay-Risperidone 21

MyCare Assay-Risperidone Product Overview 21

MyCare Assay-Thalidomide 22

MyCare Assay-Thalidomide Product Overview 22

MyCare Assay-Tyrosine Kinase Inhibitor 23

MyCare Assay-Tyrosine Kinase Inhibitor Product Overview 23

MyCare Assay-Vincristine 24

MyCare Assay-Vincristine Product Overview 24

Saladax Biomedical, Inc.-Key Competitors 25

Saladax Biomedical, Inc.-Key Employees 26

Saladax Biomedical, Inc.-Locations And Subsidiaries 27

Head Office 27

Recent Developments 28

Saladax Biomedical, Inc., Recent Developments 28

Dec 01, 2014: Saladax Biomedical Announces U.S. Launch of MyImatinib Chemotherapy Exposure Optimization Test 28

Jul 23, 2014: Fosun Diagnostics receives CFDA Clearance for the MyCare Portfolio of Chemotherapy Exposure Optimization Tests 28

Jul 23, 2014: Personalized Chemotherapy Tests Cleared for Use in China 29

Mar 31, 2014: A Dose of Reality About Chemotherapy Dosing-Saladax Has The Antidote-My5-FU 29

Oct 15, 2013: Saladax Biomedical Laboratories Receives Florida State Laboratory License 29

Jul 22, 2013: Saladax Biomedical Announces Addition to Leadership Team 30

Jun 19, 2013: Saladax Biomedical Announces US Launch Of MyCare Portfolio Of Chemotherapy Exposure Optimization Tests 30

Jun 10, 2013: Saladax Gets CLIA Laboratory Certification And Approval To Begin Clinical Laboratory Operations In Support Of MyCare Portfolio 31

Feb 11, 2013: Saladax Biomedical To Offer Full Portfolio Of MyCare Therapeutic Dose Management Assays In US 31

Dec 06, 2012: Saladax Biomedical To Establish CLIA Lab In Bethlehem, Pennsylvania 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33

List of Figures

Saladax Biomedical, Inc. Pipeline Products by Equipment Type 8

Saladax Biomedical, Inc. Pipeline Products by Development Stage 11

List of Tables

Saladax Biomedical, Inc. Pipeline Products and Clinical Trials Overview 7

Saladax Biomedical, Inc. Pipeline Products by Equipment Type 7

Saladax Biomedical, Inc. Pipeline Products by Indication 8

Saladax Biomedical, Inc., Key Facts 9

Saladax Biomedical, Inc., Major Products and Services 10

Saladax Biomedical, Inc. Number of Pipeline Products by Development Stage 11

Saladax Biomedical, Inc. Pipeline Products Summary by Development Stage 12

Diagnostic Assay-Alzheimer's Disease-Product Status 13

Diagnostic Assay-Alzheimer's Disease-Product Description 13

MyCare Assay-Busulfan-Product Status 14

MyCare Assay-Busulfan-Product Description 14

MyCare Assay-Clozapine-Product Status 15

MyCare Assay-Clozapine-Product Description 15

MyCare Assay-Cyclophosphamide-Product Status 16

MyCare Assay-Cyclophosphamide-Product Description 16

MyCare Assay-Doxorubicin-Product Status 17

MyCare Assay-Doxorubicin-Product Description 17

MyCare Assay-Gemcitabine-Product Status 18

MyCare Assay-Gemcitabine-Product Description 18

MyCare Assay-Irinotecan-Product Status 19

MyCare Assay-Irinotecan-Product Description 19

MyCare Assay-Lenalidomide-Product Status 20

MyCare Assay-Lenalidomide-Product Description 20

MyCare Assay-Risperidone-Product Status 21

MyCare Assay-Risperidone-Product Description 21

MyCare Assay-Thalidomide-Product Status 22

MyCare Assay-Thalidomide-Product Description 22

MyCare Assay-Tyrosine Kinase Inhibitor-Product Status 23

MyCare Assay-Tyrosine Kinase Inhibitor-Product Description 23

MyCare Assay-Vincristine-Product Status 24

MyCare Assay-Vincristine-Product Description 24

Saladax Biomedical, Inc., Key Employees 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Saladax Biomedical, Inc., Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 50588
Site License
USD 1500 INR 101175
Corporate User License
USD 2250 INR 151763



Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]